NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/06/2025
Back to search
Official data from USPTO
ZYTONOVA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ZYTONOVA
ST13
US500000079368062Class
1, 5, 9, 10, 35, 42, 44
Filing
79368062
Registration
7383469
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
11/07/2025
Trademark type
Word
Nice classes
1, 5, 9, 10, 35, 42, 44
Filing date
11/17/2022
Registration date
05/14/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/14/2024
Last transaction
11/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
MARTIN,JENNIFER MCGARRY
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ZytoVision GmbH
Representatives
Laurence P. Colton SMITH TEMPEL BLAHA LLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; chemical preparations for analyses in laboratoriesother than for medical or veterinary purposes; biochemicalspolynucleotidesoligonucleotidespeptidesproteinsenzymesantibodies for in vitro scientific and research purposes; chemicals and biochemicalsnucleic acids and antibodies for use in the detection of genetic alterationsother than for medical or veterinary purposes; nucleic acids and antibodies for laboratory use; chemicals for use in industry and sciencedna probesrna probes and oligonucleotide probes being biochemical substancesantibodiesenzymesoligonucleotides for carrying out molecular biological processes; mixtures of chemical reagents in kit formother than for medical or veterinary purposeskits for scientific purposes consisting primarily of chemical reagents
Class 5
Medical preparationsmedical diagnostic reagents for diagnosis of genetic disorders; medical preparations for diagnosticsmedical diagnostic reagents for diagnosis of genetic aberrations in tumors; medical preparations for in vitro diagnosticstest kits containing antibodiesprobesenzymesbuffers and reagents for diagnosis of genetic disorders including genetic aberrations in tumors; nucleic acids sequencespeptide sequenceschemical reagents for medical and veterinary purposes; biological and chemical preparationsdnarna and oligonucleotide probes composed of biochemical substancesoligonucleotidesproteins and enzymes and antibodiesall for medical and veterinary diagnostic purposes; biological and chemical preparations for medical and veterinary purposesdna probesrna probes and oligonucleotide probes being polynucleotidesbiochemical substancesoligonucleotidesproteins and enzymes and antibodies for diagnosis of genetic disorders including genetic aberrations in tumors; diagnostic biomarker reagents for medical purposes
Class 9
Research laboratory analyzers for measuringtesting and analyzing blood and other bodily fluids; analysis apparatusresearch laboratory analyzersfor measuringtesting and examining tissuecells and biomolecules including dnarna and proteins
Class 10
Medical analytical apparatus for medical purposesmedical diagnostic instruments for the analysis of dnarna and proteins; automatic analyzers for medical diagnosismedical diagnostic instruments for the analysis of body fluids and tissues; genetic testing apparatus for medical purposes
Class 35
Business management consultancy and advisory services; operation of businesses for othersnamely biotechnological and medical companies; running of a holding company performed for third partiesnamely business managementbusiness administrationproviding office functions; holding company services performed for third partiesdevelopment of marketing strategybusiness management and business management consultation; business management and organization consultation; advisory services relating to business management; business administration; providing office functions; business development servicesplanning and monitoring of business developments and organizational services for business purposes
Class 42
Science and technology servicesresearch and design in the field of genetic analyses including analyses of genetic alterations in tumors; medical laboratory services; medical research laboratory services; development of pharmaceutical preparations and medicines; clinical researchnamely conducting clinical trials for others; research relating to biotechnology; scientific consultancy services relating to hazardous materials management; biological analysisbiochemical analysischemical analysisscientific analysisdnarnaprotein analysis services for scientific research purposes; scientific research in the field of genetics and genetic engineering
Class 44
Medical services; medical diagnostic servicesmedical testing for diagnostic or treatment purposes; in-vitro analysis for medical and pharmaceutical usemedical services in the field of genetic disorders including genetic aberrations in tumors; medical services using the knowledge in the field of pathologygenetic sciencehuman geneticsmolecular pathologiesmolecular biologymicrobiologybiotechnology and laboratory medicine; medical services by means of histologycytologyimmunohistologyimmunohistochemistryin situ hybridizationpcr (polymerase chain reaction)ngs (next generation sequencing)microarray hybridization (genetic chip or biochip hybridization)flow cytometry and isolation of biomolecules including DNARNA and proteins; medical counseling; pharmaceutical compounding services; pharmaceutical advice; medical and healthcare services relating to dnagenetics and genetic testing; medical pathology servicesnamely pathology diagnostic services; genetic testing for medical purposes
Publications
History of USPTO decisions and trademark events.
33 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/30/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/09/2024
FIMP
FINAL DISPOSITION PROCESSED
11/08/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/14/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/14/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/14/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2024
GPNX
NOTIFICATION PROCESSED BY IB
02/27/2024
PUBO
PUBLISHED FOR OPPOSITION
02/27/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/23/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/22/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/22/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/13/2023
GNFR
FINAL REFUSAL E-MAILED
12/13/2023
CNFR
FINAL REFUSAL WRITTEN
12/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/09/2023
RFNT
REFUSAL PROCESSED BY IB
10/17/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/25/2023
RFRR
REFUSAL PROCESSED BY MPU
09/25/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/07/2023
CNRT
NON-FINAL ACTION WRITTEN
09/06/2023
DOCK
ASSIGNED TO EXAMINER
08/30/2023
MAFR
APPLICATION FILING RECEIPT MAILED
04/26/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/22/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/20/2023
Continuous trademark protection
Get notified about every new filing that threatens ZYTONOVA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.